Epigenome dysregulation in cholangiocarcinoma

Colm J O'Rourke; Patricia Munoz-Garrido; Esmeralda L Aguayo; Jesper B Andersen

doi:10.1016/j.bbadis.2017.06.014

Epigenome dysregulation in cholangiocarcinoma

Colm J O'Rourke, Patricia Munoz-Garrido, Esmeralda L Aguayo, Jesper B Andersen

16 Citationer (Scopus)

47 Downloads (Pure)

Abstract

Epigenomics is a fast-evolving field of research that has lately attracted considerable interest, mainly due to the reversibility of epigenetic marks. Clinically, among solid tumors, the field is still limited. In cholangiocarcinoma (CCA) it is well known that the epigenetic landscape is deregulated both during carcinogenesis and disease progression as a consequence of aberrant mechanisms leading to genome instability. In this article, we will briefly review the molecular alterations that have been described in the transformation of normal cholangiocytes into malignant derivatives, focusing on the role of non-coding RNA (ncRNA) interactions, DNA methylation, post-translational modifications (PTMs) of histones and chromatin remodeling complexes.

Originalsprog	Engelsk
Tidsskrift	BBA Molecular Basis of Disease
Vol/bind	1864
Udgave nummer	4, Part B
Sider (fra-til)	1423-1434
Antal sider	12
ISSN	0925-4439
DOI	https://doi.org/10.1016/j.bbadis.2017.06.014
Status	Udgivet - apr. 2018

Adgang til dokumentet

10.1016/j.bbadis.2017.06.014

EPIGENOME DYSREGULATION IN CHOLANGIOCARCINOMAAccepteret manuskript, 4,45 MBLicens: Ikke-specificeret

Citationsformater

@article{81b1a1f0edb64ef4b1df997535688b9c,

title = "Epigenome dysregulation in cholangiocarcinoma",

abstract = "Epigenomics is a fast-evolving field of research that has lately attracted considerable interest, mainly due to the reversibility of epigenetic marks. Clinically, among solid tumors, the field is still limited. In cholangiocarcinoma (CCA) it is well known that the epigenetic landscape is deregulated both during carcinogenesis and disease progression as a consequence of aberrant mechanisms leading to genome instability. In this article, we will briefly review the molecular alterations that have been described in the transformation of normal cholangiocytes into malignant derivatives, focusing on the role of non-coding RNA (ncRNA) interactions, DNA methylation, post-translational modifications (PTMs) of histones and chromatin remodeling complexes.",

keywords = "Journal Article, Review",

author = "O'Rourke, {Colm J} and Patricia Munoz-Garrido and Aguayo, {Esmeralda L} and Andersen, {Jesper B}",

year = "2018",

month = apr,

doi = "10.1016/j.bbadis.2017.06.014",

language = "English",

volume = "1864",

pages = "1423--1434",

journal = "B B A - Molecular Basis of Disease",

issn = "0925-4439",

publisher = "Elsevier",

number = "4, Part B",

}

TY - JOUR

T1 - Epigenome dysregulation in cholangiocarcinoma

AU - O'Rourke, Colm J

AU - Munoz-Garrido, Patricia

AU - Aguayo, Esmeralda L

AU - Andersen, Jesper B

PY - 2018/4

Y1 - 2018/4

N2 - Epigenomics is a fast-evolving field of research that has lately attracted considerable interest, mainly due to the reversibility of epigenetic marks. Clinically, among solid tumors, the field is still limited. In cholangiocarcinoma (CCA) it is well known that the epigenetic landscape is deregulated both during carcinogenesis and disease progression as a consequence of aberrant mechanisms leading to genome instability. In this article, we will briefly review the molecular alterations that have been described in the transformation of normal cholangiocytes into malignant derivatives, focusing on the role of non-coding RNA (ncRNA) interactions, DNA methylation, post-translational modifications (PTMs) of histones and chromatin remodeling complexes.

AB - Epigenomics is a fast-evolving field of research that has lately attracted considerable interest, mainly due to the reversibility of epigenetic marks. Clinically, among solid tumors, the field is still limited. In cholangiocarcinoma (CCA) it is well known that the epigenetic landscape is deregulated both during carcinogenesis and disease progression as a consequence of aberrant mechanisms leading to genome instability. In this article, we will briefly review the molecular alterations that have been described in the transformation of normal cholangiocytes into malignant derivatives, focusing on the role of non-coding RNA (ncRNA) interactions, DNA methylation, post-translational modifications (PTMs) of histones and chromatin remodeling complexes.

KW - Journal Article

KW - Review

U2 - 10.1016/j.bbadis.2017.06.014

DO - 10.1016/j.bbadis.2017.06.014

M3 - Review

C2 - 28645654

SN - 0925-4439

VL - 1864

SP - 1423

EP - 1434

JO - B B A - Molecular Basis of Disease

JF - B B A - Molecular Basis of Disease

IS - 4, Part B

ER -

Epigenome dysregulation in cholangiocarcinoma

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater